Business Wire

TX-SOFTSERVE

30.8.2022 13:06:40 CEST | Business Wire | Press release

Share
SoftServe Releases 2021 Sustainability Report

SoftServe, a leading digital authority and consulting company, has released the company’s sustainability report for 2021. Prepared in accordance with GRI standards, the report highlights SoftServe’s commitment to sustainability practices as a dedicated member of the United Nations Global Compact. The report provides an overview of the company’s corporate social responsibility (CSR) initiatives, including governance of CSR, IT education, environmental management, and progress in diversity, equity, and inclusion (DE&I).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220830005028/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Report demonstrates the company’s commitment to sustainability practices and obligations as a member of the United Nations Global Compact. (Photo: Business Wire)

“SoftServe’s mission is to empower talented people to change the world,” said Chris Baker, CEO. “We stay committed to that mission by making our clients successful, developing our teams and ourselves while innovating every day. This Sustainability Report reflects our ongoing commitment to bringing a sustainable future to our clients, associates, and communities.”

Governance of CSR

SoftServe maintains five cross-functional sustainability councils overseeing individual CSR initiatives. Each council consists of contributors from specific business groups and is overseen by a chairperson and an executive sponsor to ensure effective decision-making processes. As many as 70 leaders throughout the organization are engaged in councils and contribute their efforts to building sustainable practices and scaling impact across the business.

IT Education

IT education and training for qualified specialists remains one of the key areas of corporate social responsibility of the company. SoftServe collaborates with 64 universities around the world, and in 2021 alone, introduced four undergraduate programs with a dual form of education combining theoretical classes with corporate practice.

SoftServe University, which celebrated its 15th anniversary last year, is developing a variety of solutions for both in-house training and for those looking to start an IT career. Out of 2,282 SoftServe IT Academy interns in 2021, most secured a new career with SoftServe - 120% more than a year earlier.

Environment

Last year, SoftServe reduced the number of direct emissions from the production of goods by 55.4% compared to the previous year. The company also introduced a new approach to environmental management and set ambitious environmental goals by 2031. These goals include becoming a zero-carbon business, achieving zero waste, designing environmentally sustainable offices, and developing IT solutions to help meet environmental challenges.

Diversity, Equity, and Inclusion

Principles of diversity, equity, and inclusion drive a culture at SoftServe where every associate has the same opportunity for growth and advancement. The company’s special Diversity, Equity & Inclusion Council works to adhere to these principles and promotes constant progress through operational action.

In addition, SoftServe is a globally responsible employer striving to make each associate’s learning journey as inclusive as possible. Over the last two years, and throughout rapid corporate expansion, SoftServe prioritized accessible office construction and inclusive learning design, and a recent accessibility audit shows an 18% increase in entirely accessible offices.

Click here for more information on SoftServe’s sustainability report.

About SoftServe

SoftServe is a digital authority that advises and provides at the cutting-edge of technology. We reveal, transform, accelerate, and optimize how enterprises and software companies do business. Our end-to-end solutions and expertise deliver innovation, quality, and speed across the healthcare, retail, energy, manufacturing, and financial services verticals. We empower enterprises and software companies to (re)identify differentiation, accelerate solution development, and vigorously compete in today’s marketplace—no matter where you are in your journey.

Visit our website, blog, LinkedIn, Facebook, and Twitter.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220830005028/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release

Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa

EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release

EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia

Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release

Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye